-
1 Comment
Chongqing Pharscin Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 5.4% below its 200 day moving average.
From a valuation standpoint, the stock is 36.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.1.
Chongqing Pharscin Pharmaceutical Co., Ltd's total revenue rose by 11.0% to $245M since the same quarter in the previous year.
Its net income has dropped by 30.0% to $32M since the same quarter in the previous year.
Finally, its free cash flow fell by 96.7% to $1M since the same quarter in the previous year.
Based on the above factors, Chongqing Pharscin Pharmaceutical Co., Ltd gets an overall score of 2/5.
Chongqing Pharscin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China and internationally. It offers generic drugs, traditional Chinese medicines, and food for special medical purposes in various forms, including tablets, granules, capsules, soft capsules, powders, powder injections, lyophilized powder injections, small-volume injections, chemical raw materials, and traditional Chinese medicine extracts. The company is also involved in the provision of CDMO and CMO services; pharmaceutical technology development services and consulting; wholesale and retail activities; and scientific research and technical services. Its products are used in digestive diseases, central nervous system disorders, and otolaryngology therapeutic areas. The company was incorporated in 1996 and is headquartered in Chongqing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002907.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
